These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients. Thobois S; Mertens P; Guenot M; Hermier M; Mollion H; Bouvard M; Chazot G; Broussolle E; Sindou M J Neurol; 2002 May; 249(5):529-34. PubMed ID: 12021940 [TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease. Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947 [TBL] [Abstract][Full Text] [Related]
26. End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation. Apetauerova D; Ryan RK; Ro SI; Arle J; Shils J; Papavassiliou E; Tarsy D Mov Disord; 2006 Aug; 21(8):1277-9. PubMed ID: 16637040 [TBL] [Abstract][Full Text] [Related]
27. Extradural motor cortex stimulation in Parkinson's disease. Cilia R; Landi A; Vergani F; Sganzerla E; Pezzoli G; Antonini A Mov Disord; 2007 Jan; 22(1):111-4. PubMed ID: 17083104 [TBL] [Abstract][Full Text] [Related]
28. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa. Lyons KE; Davis JT; Pahwa R Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749 [TBL] [Abstract][Full Text] [Related]
29. Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease. Sauleau P; Leray E; Rouaud T; Drapier S; Drapier D; Blanchard S; Drillet G; Péron J; Vérin M Mov Disord; 2009 Oct; 24(14):2149-55. PubMed ID: 19735089 [TBL] [Abstract][Full Text] [Related]
30. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Volkmann J; Albanese A; Kulisevsky J; Tornqvist AL; Houeto JL; Pidoux B; Bonnet AM; Mendes A; Benabid AL; Fraix V; Van Blercom N; Xie J; Obeso J; Rodriguez-Oroz MC; Guridi J; Schnitzler A; Timmermann L; Gironell AA; Molet J; Pascual-Sedano B; Rehncrona S; Moro E; Lang AC; Lozano AM; Bentivoglio AR; Scerrati M; Contarino MF; Romito L; Janssens M; Agid Y Mov Disord; 2009 Jun; 24(8):1154-61. PubMed ID: 19412954 [TBL] [Abstract][Full Text] [Related]
34. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959 [TBL] [Abstract][Full Text] [Related]
35. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Østergaard K; Sunde N; Dupont E Mov Disord; 2002 Jul; 17(4):693-700. PubMed ID: 12210858 [TBL] [Abstract][Full Text] [Related]
36. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus. Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116 [TBL] [Abstract][Full Text] [Related]
37. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Vitek JL; Bakay RA; Freeman A; Evatt M; Green J; McDonald W; Haber M; Barnhart H; Wahlay N; Triche S; Mewes K; Chockkan V; Zhang JY; DeLong MR Ann Neurol; 2003 May; 53(5):558-69. PubMed ID: 12730989 [TBL] [Abstract][Full Text] [Related]